Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
London
SEC filing record 1 source field available
Fiscal year end
31 December
Mereo BioPharma Group plc has filed 433 SEC EDGAR filings since 01 Dec 2017

SEC filing history

Showing 151-175 of 433 matching filings.

Per page
25
Current page
7
SC 13G/A File 005-91444

SC 13G/A filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
06 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91444

MEREO BIOPHARMA GROUP PLC.

Filing date
05 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Jan 2024
Reporting date
25 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Jan 2024
Reporting date
25 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Jan 2024
Reporting date
25 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Jan 2024
Reporting date
25 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Jan 2024
Reporting date
25 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-276656

S-8

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .